Advertisement

Repeat hepatic resection for recurrent colorectal liver metastases: If at first you don’t succeed, try, try again?

Published:December 27, 2022DOI:https://doi.org/10.1016/j.surg.2022.11.026
      In the current issue of Surgery, Sutton et al described the outcomes of patients with intrahepatic recurrence of colorectal liver metastases (CRLM) undergoing repeat hepatic resection (RHR), compared to a propensity-matched cohort of patients treated with systemic therapy alone (SYS).

      Sutton TL, Wong LH, Walker BS, et al. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: a propensity-matched analysis [e-pub ahead of print]. Surgery. https://doi.org/10.1016/j.surg.2022.10.019. Accessed December 21, 2022.

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Sutton TL, Wong LH, Walker BS, et al. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: a propensity-matched analysis [e-pub ahead of print]. Surgery. https://doi.org/10.1016/j.surg.2022.10.019. Accessed December 21, 2022.

        • Valenzuela C.D.
        • Moaven O.
        • Gawdi R.
        • et al.
        Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC).
        J Surg Oncol. 2022; 126: 1242-1252
        • Dijkstra M.
        • Nieuwenhuizen S.
        • Puijk R.S.
        • et al.
        Thermal ablation compared to partial hepatectomy for recurrent colorectal liver metastases: an Amsterdam Colorectal Liver Met Registry (AmCORE) based study.
        Cancers (Basel). 2021; 13: 2769
        • Muaddi H.
        • D’Angelica M.
        • Wiseman J.T.
        • et al.
        Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: a multicenter, retrospective cohort study.
        J Surg Oncol. 2021; 123: 252-260
        • Lambdin J.
        • Ryan C.E.
        • Alejandro R.H.
        • et al.
        Neoadjuvant chemotherapy plus living donor transplantation (LDLT) for non-resectable liver metastases from colorectal cancer (CRC).
        Ann Surg Oncol. 2023; 30: 18-20

      Linked Article